Financial News · Live Terminal

Page 20 of 171

Jefferies Downgrades Kennametal to Hold From Buy, Price Target is $47.50

Kennametal (KMT) has an average rating of hold and mean price target of $38, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$KMT

Research2d ago

Research Alert: Nutrien: Pricing Strength Helps Offset Volume Headwinds, Q1 Eps Beats Estimates

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Nutrien delivered robust Q1 results with adjusted EPS of $0.51 significantly outperforming the prior year's $0.11, while adjusted EBITDA increased 30% to $1.11B. Sales rose 19% to $6.05B, supported by record potash volumes of 3.51M tonnes and higher fertilizer benchmarks across all segments. Potash delivered exceptional performance with record sales volumes and improved pricing power, generating adjusted EBITDA of $578M on higher net selling prices of $264/tonne. Management reaffirmed all 2026 guidance ranges, including Retail adjusted EBITDA of $1.75-$1.95B and potash sales volumes of 14.1-14.8M tonnes. Retail operations demonstrated resilience with adjusted EBITDA surging 135% to $108M despite ongoing farm sector financial stress, while Nitrogen benefited from stronger global benchmarks though production volumes declined due to facility shutdowns. The company returned $409M to shareholders through dividends and share repurchases.

$NTR

Research2d ago

Research Alert: Celh: Q1 Well-ahead Of Expectations; Shares Jump 5%

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Celsius Holdings (CELH) posted Q1 adjusted EPS of $0.41 vs. $0.18 (+128%), well-ahead of the $0.29 consensus. CELH's net sales rose 138% to $782.6M ($22.0M above consensus) but gross margin contracted 400 bps to 48.3% (40 bps below consensus) due to acquisition mix and integration costs. The strength of the top line was largely due to the Alani Nu and Rockstar Energy acquisitions which respectively contributed $368M and $67M of sales to the top line. The portfolio's retail performance showed mixed results, with Alani Nu delivering robust 100% Y/Y growth while the legacy CELSIUS brand grew 6%, and Rockstar Energy declined 13%. In Q1, CELH repurchased $24M of stock. CELH shares are trading 6% higher in pre-market trading on the big bottom-line beat. While we weren't thrilled by the company's 2025 acquisition of Rockstar Energy and how the growth of its legacy CELSIUS brand has slowed dramatically, the Alani Nu acquisition was a transformational deal which continues to pay off and drive growth.

$CELH

Research2d ago

Research Alert: Epam Modestly Lowers Fy 26 Revenue Forecast, Offset By Improved Eps View

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:EPAM reported Q1 sales of $1.400B (+8% Y/Y), beating consensus ($1.394B), with organic growth of 3.7% decelerating from 5.6% in Q4 and 7.1% in Q3 but up from 1.4% growth in Q1 2025. Growth was led by Financial Services (+12%) and Software & Hi-Tech (+11%), with Business Information & Media (-0.7%) underperforming. Non-GAAP EPS of $2.86 (+19%) beat expectations ($2.75), with help from operating margin expanding 80 bps Y/Y (to 14.3%) and $324M of share repurchases. Management disappointingly lowered 2026 revenue guidance to a midpoint of 5.25% from a prior view of 6.0% (organic CC 3.75% vs. prior 4.5%) but raised EPS guidance to a midpoint of $13.13 from $12.59 as profitability improves and share count declines. While the lower sales view may fuel bears' AI competition fears, we suspect the downtick relates more to rising macro uncertainty, and we are encouraged by continued efficiency gains. Fixed-price contracts continue rising (21.7% of sales, +260 bps Y/Y), creating opportunities for margin outperformance.

$EPAM

Research2d ago

Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35

QuidelOrtho (QDEL) has an average rating of hold and mean price target of $18.10, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$QDEL

Research2d ago

Research Alert: Zts Posts Mixed Q1 With U.s. Headwinds, International Growth, Revises Guidance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:ZTS delivered challenging Q1 2026 results with adjusted EPS of $1.53 (+9% Y/Y) missing the consensus view of $1.62, while revenue of $2.262B (+3% Y/Y) met expectations. Performance reflected divergent regional dynamics, with International segment growth of 17% Y/Y ($1.149B) offsetting an 8% Y/Y decline in the U.S. segment ($1.090B). The company faced intensified competitive pressure in key dermatology franchises and heightened macroeconomic headwinds affecting U.S. pet owners, leading to reduced veterinary visits and softer demand for premium products. Management revised full-year 2026 guidance to $9.680B-$9.960B for revenue (2%-5% organic operational growth) and adjusted EPS of $6.85-$7.00, acknowledging current market pressures. We believe ZTS could be well-positioned for long-term growth with its portfolio breadth, robust pipeline of potential blockbusters, and proven innovation capabilities as key competitive advantages if it successfully navigates near-term headwinds.

$ZTS

Research2d ago

Research Alert: Mcd: Q1 Eps Beats And Comps Improve Amid A Challenging Environment

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:MCD's Q1 global comparable sales of +3.8% met consensus and represented sharp acceleration from -1.0% the prior year, with U.S. comps inflecting to +3.9% from -3.6% and International Operated Markets improving to +3.9% from -1.0%. Adjusted EPS of $2.83 grew 6% and beat the$2.74 consensus, while adjusted operating income rose 11% as operating leverage materialized in the franchised model. The print reinforces the recovery narrative with value strategy gaining traction, evidenced by positive U.S. check growth indicating successful promotional initiatives. Management expects approximately 2,100 net restaurant additions and operating margins in the mid-to-high 40% range for 2026. The loyalty program remains a key driver with over $9B in quarterly systemwide sales across 70 markets. We believe the results validate that MCD's value positioning is resonating and should support investor confidence in the earnings trajectory, though traffic trends remain a key focus area for sustained momentum.

$MCD

Research2d ago

Research Alert: Nutrien: Pricing Strength Helps Offset Volume Headwinds, Q1 Eps Beats Estimates

$NTR

Research2d ago

Research Alert: Trex Q1 2026: Strategic Pivot And Strong Capital Returns Amid Market Headwinds

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Trex delivered resilient Q1 2026 results with net sales up 1% to $343M and gross margin holding at 40.5% despite $4M in additional depreciation from the new Little Rock facility. Net income rose to $61M ($0.58/share) while adjusted EBITDA improved 2% to $103M, demonstrating strong cash generation amid residential market headwinds. New CEO Adam Zambanini launched five strategic priorities focused on end-user relationships and innovation, while the company expanded its PVC decking rollout and executed aggressive capital returns with $150M in share repurchases. Management reaffirmed 2026 guidance of $1.185-1.23B revenue and $315-340M adjusted EBITDA despite down-to-flat R&R markets. We believe the company is well-positioned for significant free cash flow expansion as capex returns to maintenance levels of 5-6% of revenue in 2027, while strategic initiatives and a strong balance sheet support long-term growth despite near-term market challenges.

$TREX

Research2d ago

Research Alert: Kenvue Reports Solid Q1 Performance Amidst Pending Kimberly-clark Acquisition

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Kenvue (KVUE) delivered solid Q1 results with net sales of $3,909M (+4.5% Y/Y) and organic growth of 0.7%, marking the second consecutive quarter of growth. Diluted EPS surged to $0.25 vs. $0.17 (+47%) while adjusted EPS reached $0.32 vs $0.24 (+33%), due to significant margin expansion with gross margin improving 90bps to 58.9% and operating margin jumping 470bps to 19.6%. The strong performance demonstrates operational momentum ahead of the pending Kimberly-Clark acquisition, with supply chain optimization and cost management initiatives driving results. . Segment performance was mixed, with Skin Health & Beauty leading at +8.4% growth while Self Care faced headwinds from weak cold/flu seasons, posting an organic sales decline of 2.3%. Since management is no longer providing forward guidance and hosting an analyst call due to the transaction expected to close during 2H 2026, we have limited visibility into KVUE's performance expectations at this point.

$KVUE

Research2d ago

Vermilion Energy Target Eased To C$27 From $30, Keeps Outperform at National Bank, Notes "Consistent Well Performance Across Portfolio Underpins Momentum"

$VET.TO

Research2d ago

Sprott Price Target Raised to $230 at RBC

RBC Capital Markets raised its price targets on Sprott Inc. (SII.TO, SII) to $230 from $218 on Thursday.Analyst Bart Dziarski maintained an Outperform rating on shares of the Toronto-based alternative asset manager following its quarterly results on Wednesday.The stock rose $34.27, or approximately 20%, to $207.65 on the Toronto Stock Exchange."Momentum continues across Sprott's business lines, highlighting embedded operating leverage to constructive commodity pricing compounded by net inflows accentuated by adjusted EBITDA margin reaching 72%," Dziarski said in a note to clients.

$SII$SII.TO

Research2d ago

Oppenheimer Initiates Aprea Therapeutics at Outperform With $5 Price Target

$APRE

Research2d ago

Wells Fargo Downgrades Criteo to Equalweight From Overweight, Cuts Price Target to $18 From $34

Criteo (CRTO) has an average rating of overweight and mean price target of $25.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CRTO

Research2d ago

BMO Capital Upgrades Louisiana-Pacific to Outperform From Market Perform, Maintains $94 Price Target

Louisiana-Pacific (LPX) has an average rating of overweight and mean price target of $93.09, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$LPX

Research2d ago

JPMorgan Upgrades Freshpet to Overweight From Neutral, Adjusts Price Target to $68 From $66

Freshpet (FRPT) has an average rating of overweight and mean price target of $81.60, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$FRPT

Research2d ago

Citigroup Initiates Innovex International at Buy With $35 Price Target

Innovex International (INVX) has an average rating of buy and mean price target of $31.75, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$INVX

Research2d ago

BTIG Downgrades Accuray to Neutral From Buy, Price Target is $2

$ARAY

Research2d ago

Alliance Global Downgrades Modiv Industrial to Neutral From Buy, Price Target is $18

Modiv Industrial (MDV) has an average rating of hold and mean price target of $18.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$MDV

Research2d ago

KeyBanc Downgrades Angi to Sector Weight From Overweight, Price Target is $11

Angi Inc (ANGI) has an average rating of hold and mean price target of $10.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ANGI

Showing 381-400 of 3404